How the World Bank Delivered COVID Vaccines in East Asia and the Pacific

 

STORY HIGHLIGHTSVaccine-Story-1

  • The World Bank has provided US$1.44 billion to support the purchase and distribution of COVID-19 vaccines, tests, and treatments in the East Asia and the Pacific (EAP) region, especially for the poor and vulnerable.
  • Strong partnerships and flexible financing approaches have helped countries ramp up their vaccination programs while investing in health, education, and social protection to ensure a more resilient future.
  • Based on the current pace of vaccination and availability of vaccines to EAP countries, most will achieve at least 70% coverage by mid-2022.

COVAX and World Bank to Accelerate Vaccine Access for Developing Countries

New mechanism builds on Gavi COVAX Advance Market Commitment (AMC) cost-sharing arrangement

WASHINGTON, July 26, 2021 – COVAX and the World Bank will accelerate COVID-19 vaccine supply for developing countries through a new financing mechanism that builds on Gavi’s newly designed AMC cost-sharing arrangement. This allows AMC countries to purchase doses beyond the fully donor-subsidized doses they are already receiving from COVAX.

Continue reading